USPTO serial 79003254
PLIAZON
Reviewed by CopyMark Law Group
Reg. 3023875Status 404
- Filing date
- Status date
- Registration date
- Dec 6, 2005
- Examiner
- BOAGNI, MARY
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with PLIAZON?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
H. John Campaign
H JOHN CAMPAIGN GRAHAM CAMPAIGN PC36 W 44TH STNEW YORK, NY 10036-8178UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical preparations for human use for the prevention and treatment of cancer | SECTION 71 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Nov 7, 2014 | INNT | TOTAL INVALIDATION PROCESSED BY THE IB | — |
| Oct 30, 2014 | DENC | NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED | — |
| Oct 30, 2014 | DETH | DEATH OF INTERNATIONAL REGISTRATION | — |
| Jul 17, 2014 | INTS | TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB | — |
| Apr 30, 2014 | INTR | TOTAL INVALIDATION OF REG EXT PROTECTION CREATED | — |
| Aug 30, 2013 | C71T | CANCELLED SECTION 71 | — |
| Sep 28, 2007 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Jul 27, 2006 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Jul 27, 2006 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Jul 16, 2006 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Dec 6, 2005 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Sep 13, 2005 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Aug 24, 2005 | NPUB | NOTICE OF PUBLICATION | — |
| Jul 29, 2005 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Apr 18, 2005 | ALIE | ASSIGNED TO LIE | — |
| Apr 15, 2005 | ALIE | ASSIGNED TO LIE | — |
| Apr 14, 2005 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Apr 1, 2005 | ACEC | AMENDMENT FROM APPLICANT ENTERED | — |
| Mar 17, 2005 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Mar 17, 2005 | PAPER RECEIVED | — | |
| Dec 23, 2004 | RFNT | REFUSAL PROCESSED BY IB | — |
| Nov 18, 2004 | CNRT | NON-FINAL ACTION MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Nov 9, 2004 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 27, 2004 | DOCK | ASSIGNED TO EXAMINER | — |
| Jul 19, 2004 | NWAP | NEW APPLICATION ENTERED | — |
| Jul 15, 2004 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |